help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cole, L. A.
Right arrow Articles by Braunstein, G. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cole, L. A.
Right arrow Articles by Braunstein, G. D.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Hazardous Substances DB
*CHORIONIC GONADOTROPIN
Medline Plus Health Information
*Pregnancy

Journal of Clinical Endocrinology & Metabolism, Vol 76, 704-710, Copyright © 1993 by Endocrine Society


ARTICLES

The deactivation of hCG by nicking and dissociation

LA Cole, A Kardana, SY Park and GD Braunstein
Department of Obstetrics and Gynecology, Yale University School of Medicine, New Haven Connecticut 06510.

Human chorionic gonadotropin (hCG) is composed of an alpha- and a beta- subunit, joined noncovalently. A proportion of hCG molecules in pregnancy serum and urine samples have nicks or a missing peptide linkage between either beta-subunit residues 44 and 45 or beta-subunit residues 47 and 48. These nicks ablate the steroidogenic activity of hCG. We examined the source of nicking, and the occurrence and stability of nicked hCG molecules produced during pregnancy. We investigated the source of nicking. Standard hCG was added to three samples of whole blood, and incubated 18 h at 37 C. No change in extent of nicking was detected. However, nicking of hCG beta-subunit was detected by gel electrophoresis (bands at M(r) = 17,000 and M(r) = 22,000, corresponding to the peptides beta 1-47(44) and beta 48(45)- 145, respectively) in culture fluids from first trimester placental explants and from JAr malignant trophoblast cells. We inferred that nicking occurs before or immediately upon secretion by trophoblast tissue. We examined the occurrence of nicking. Levels of total hCG (nicked+nonnicked) and intact hCG (nonnicked) were determined in 233 serum and 168 urine samples from 4-40 weeks of pregnancy. From the two measurements the extent of nicking was estimated. A linear relationship was indicated between advancing weeks of gestation and increasing extent of nicking (regression analysis, months vs. percent nicked, 95% correlation). Minimum nicking was observed in serum from the first 2 months of pregnancy (mean = 9% of hCG molecules), increased nicking in the months after, and maximum nicking in samples from the last 2 months of pregnancy (mean = 21% of hCG molecules, t test first 2 months vs. last 2 months, P < 0.00005). Similar results were observed with urine samples (first 2 months mean = 9%, last 2 months = 27%, t test P < 0.00005). We concluded that nicking is more prevalent after the hCG peak (after 2 months of pregnancy). Finally, we examined the stabilities of nicked and intact hCG molecules. Standard hCG (batch CR127, 20% nicked) and hCG preparation C5 (100% nicked) were incubated for varying times in whole blood. C5 hCG dissociated rapidly into free alpha- and beta-subunits (dissociation half-life 22 +/- 5.2 h), over 30 times faster than standard hCG (dissociation half-life 700 h).(ABSTRACT TRUNCATED AT 400 WORDS)


This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
N. A. Khan, D. Susa, J. W. van den Berg, M. Huisman, M. H. Ameling, S. van den Engel, H. P. Roest, J. N. M. IJzermans, W. A. Dik, R. Benner, et al.
Amelioration of renal ischaemia-reperfusion injury by synthetic oligopeptides related to human chorionic gonadotropin
Nephrol. Dial. Transplant., September 1, 2009; 24(9): 2701 - 2708.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. M. Gronowski, M. Cervinski, U.-H. Stenman, A. Woodworth, L. Ashby, and M. G. Scott
False-Negative Results in Point-of-Care Qualitative Human Chorionic Gonadotropin (hCG) Devices Due to Excess hCG{beta} Core Fragment
Clin. Chem., July 1, 2009; 55(7): 1389 - 1394.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
S.F. de Medeiros and R.J. Norman
Human choriogonadotrophin protein core and sugar branches heterogeneity: basic and clinical insights
Hum. Reprod. Update, January 1, 2009; 15(1): 69 - 95.
[Abstract] [Full Text] [PDF]


Home page
Hum Reprod UpdateHome page
P. Rodien, N. Jordan, A. Lefevre, J. Royer, C. Vasseur, F. Savagner, A. Bourdelot, and V. Rohmer
Abnormal stimulation of the thyrotrophin receptor during gestation
Hum. Reprod. Update, March 1, 2004; 10(2): 95 - 105.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
F. M. Reis, D. D'Antona, and F. Petraglia
Predictive Value of Hormone Measurements in Maternal and Fetal Complications of Pregnancy
Endocr. Rev., April 1, 2002; 23(2): 230 - 257.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Mock, G. Kovalevskaya, J. F. O'Connor, and A. Campana
Choriocarcinoma-like human chorionic gonadotrophin (HCG) and HCG bioactivity during the first trimester of pregnancy
Hum. Reprod., October 1, 2000; 15(10): 2209 - 2214.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. K. Iles, M. K. Javid, L. K. Gunn, and T. Chard
Cross-Reaction with Luteinizing Hormone ß-Core Is Responsible for the Age-dependent Increase of Immunoreactive ß-Core Fragment of Human Chorionic Gonadotropin in Women with Nonmalignant Conditions
Clin. Chem., April 1, 1999; 45(4): 532 - 538.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
G. Kovalevskaya, S. Birken, T. Kakuma, J. Schlatterer, and J. F. O'Connor
Evaluation of Nicked Human Chorionic Gonadotropin Content in Clinical Specimens by a Specific Immunometric Assay
Clin. Chem., January 1, 1999; 45(1): 68 - 77.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Nemansky, E. Moy, C. D. Lyons, I. Yu, and D. L. Blithe
Human Endometrial Stromal Cells Generate Uncombined {alpha}-Subunit from Human Chorionic Gonadotropin, Which Can Synergize with Progesterone to Induce Decidualization
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 575 - 581.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
L. A. Cole
Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites
Clin. Chem., December 1, 1997; 43(12): 2233 - 2243.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society